Related Experiment Videos
The European Medicines Agency Experience With Pediatric Dose Selection
Efthymios Manolis1,2, Flora T Musuamba2,3, Kristin E Karlsson2,4
1Scientific Evidence Generation Department, Human Medicines Division, European Medicines Agency, Amsterdam, The Netherlands.
Journal of Clinical Pharmacology
|June 29, 2021
Summary
Determining optimal pediatric drug dosing presents significant challenges. This article outlines guiding principles for pediatric dose selection, leveraging adult data and considering growth and maturation.
Area of Science:
- Pharmacology
- Pediatric Medicine
- Drug Development
Background:
- Establishing appropriate pediatric drug dosage regimens faces scientific, practical, and ethical hurdles.
- Leveraging existing adult data is crucial for optimizing pediatric study design and data analysis.
- Childhood growth and maturation are critical factors in pediatric dose selection.
Purpose of the Study:
- To summarize the European Medicines Agency's experience in pediatric dose selection.
- To propose guiding principles for pediatric dose determination.
Main Methods:
- Review of European Medicines Agency's experience and methodologies.
- Application of model-informed approaches for dose-exposure-response characterization.
- Adaptation of study designs for pediatric populations.
Main Results:
- Identification of key challenges in pediatric dosing.
- Emphasis on utilizing adult data and understanding developmental processes.
- Development of adaptive study designs and model-informed strategies.
Conclusions:
- Model-informed approaches and adaptive study designs are essential for pediatric dose selection.
- General principles are proposed for defining pediatric study objectives, designs, and methodologies.
- Optimizing pediatric dosing requires a comprehensive strategy considering growth and available data.